DIALYSIS · CCN 552810

USRC Grand Home

LOS ANGELES, CA 90017

DialysisProfitUS Renal Care, Inc.
$4.3M
TOTAL REVENUE
-3.7%
OPERATING MARGIN
5 / 5
STAR RATING
12
QUALITY MEASURES
US Renal Care, Inc.
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.3M
Total costs
$4.5M
Operating income (rev − costs)
−$162K
Operating margin
-3.7%
Total charges
$4.3M
Total treatments
12,671
Dialysis stations
—

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Percentage of Adult PD Patients with Kt/V >= 1.7
DFC_ADULT_PD_KTV
9890—
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.0845—
Five Star Rating
DFC_FIVE_STAR
5——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
1.9450—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
134.162—
Percentage of Adult Patients with Hypercalcemia
DFC_HYPERCALCEMIA
090—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
19260—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
36.888—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
17.838—
Standardized ED Visits Ratio
DFC_SEDR
0.4142—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
13.340—